CLINICAL RESPONSE TO RITUXIMAB IS ASSOCIATED WITH PREVENTION OF B-CELL DRIVEN SALIVARY GLAND INFLAMMATION AND EPITHELIAL RESTORATION AS REVEALED BY MOLECULAR PATHOLOGY: RESULTS FROM THE TRACTISS TRIAL IN PRIMARY SJOGREN'S SYNDROME
Volume
81
Pagination
299 - 300
DOI
10.1136/annrheumdis-2022-eular.4458
Journal
ANNALS OF THE RHEUMATIC DISEASES
ISSN
0003-4967